Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulation of IL33, Endocan and Their Targets in Primary Human Endothelial Cells

NCT03984383 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03984383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulation of IL33, Endocan and Their Targets in Primary Human Endothelial Cells
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Withdrawn
Start date
November 8, 2021
Completion date
November 8, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial cell